Concepedia

Lisa Dillon

LD

Statistics

Publications

8

Citations

368

H-Index

8

Active since

2003

Affiliations

Pfizer (United States)(Current)

Lisa Dillon is an author at Pfizer (United States) specializing in pharmacology, medicinal chemistry, and hmg-coa reductase inhibitors.

Publications per year

2003–2010

8

Publications

8

Mapping dominant-negative mutations of anthrax protective antigen by scanning mutagenesis

Michaël Mourez, Ming Yan, D. Borden Lacy et al. · Proceedings of the National Academy of Sciences · 2003 · 84 citations · Full text

, , +13

Substituted Pyrazoles as Hepatoselective HMG-CoA Reductase Inhibitors: Discovery of (3<i>R</i>,5<i>R</i>)-7-[2-(4-Fluoro-phenyl)-4-isopropyl-5-(4-methyl-benzylcarbamoyl)-2<i>H</i>-pyrazol-3-yl]-3,5-dihydroxyheptanoic Acid (PF-3052334) as a Candidate for the Treatment of Hypercholesterolemia

Jeffrey A. Pfefferkorn, Chulho Choi, Scott D. Larsen et al. · Journal of Medicinal Chemistry · 2007 · 59 citations · Full text

, , +17

Hepatoselectivity of statins: Design and synthesis of 4-sulfamoyl pyrroles as HMG-CoA reductase inhibitors

William K.C. Park, Robert M. Kennedy, Scott D. Larsen et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 55 citations · Full text

, , +10

Design and synthesis of hepatoselective, pyrrole-based HMG-CoA reductase inhibitors

Jeffrey A. Pfefferkorn, Yuntao Song, Kuai-Lin Sun et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 55 citations · Full text

, , +12

Design and synthesis of novel, conformationally restricted HMG-CoA reductase inhibitors

Jeffrey A. Pfefferkorn, Chulho Choi, Yuntao Song et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 41 citations · Full text

, , +12

1–5 of 8